MedPath

Comparison of Three Technical Airway Clearance in Mechanical Ventilated Patients

Not Applicable
Completed
Conditions
Mucociliary Clearance Defect
Physical Disability
Registration Number
NCT02604082
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Randomized clinical trial, conducted in the Intensive Care Unit of the Hospital de Clinicas de Porto Alegre from october 2011 until november 2015 .

Detailed Description

Objective: To compare the effectiveness of techniques: vibrocompression (G1), hyperinflation with mechanical ventilation (G2) vibrocompression + hyperinflation with mechanical ventilation (G3) in the amount of aspirated secretions, mechanical ventilator time, incidence of ventilator-associated pneumonia , reintubation tracheal and mortality in mechanical ventilator. Primary outcome: weight in grams of the aspirated secretions. Secondary outcome: hemodynamic and pulmonary parameters: heart rate, respiratory rate, mean arterial pressure, peripheral arterial oxygen saturation; peak inspiratory pressure, tidal volume; dynamic compliance ; mechanical ventilator time; reintubation tracheal; Incidence of ventilator-associated pneumonia and mortality in mechanical ventilator.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
93
Inclusion Criteria
  • In mechanical ventilation for a period of 24-72 h
  • End-expiratory pressure (PEEP) lower 10 cm of water.
  • Lower noradrenaline doses of 0.5mg / kg / minute for an average greater than or equal blood outstrips 60 mmHg.
Exclusion Criteria
  • Pneumothorax and hemothorax undrained
  • Subcutaneous emphysema
  • Osteoporosis
  • Acute respiratory distress syndrome - (ARDS)
  • Fractures of ribs
  • Obese ( BMI greater than 35)
  • Mechanical ventilator with higher peak pressures 40 cm of water.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Weight in grams of the pulmonary secretionsup to 24 weeks.
Secondary Outcome Measures
NameTimeMethod
Time mechanical ventilator (MV) in daysThrough study completion, an average of 3 years.
Reintubation tracheal in percentage in the last 24 hoursThrough study completion, an average of 3 years.
Incidence of ventilator-associated pneumonia in percentageThrough study completion, an average of 3 years.
Mortality in the MV in percentageThrough study completion, an average of 3 years.
Heart Rateup to 24 weeks.
Respiratory frequencyup to 24 weeks
Peripheral oxygen saturation in percentageup to 24 weeks
Tidal volume in millilitersup to 24 weeks
Peak inspiratory pressure in centimeters of waterup to 24 weeks

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.